Cargando…
The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes
AIMS: In many physiologic systems, the evolution from health to disease correlates with a loss of complexity in the system’s output. We analyze the difference in complexity of the glycemic profile in healthy volunteers (H), patients with the metabolic syndrome (MS), and patients with type 2 diabetes...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052716/ https://www.ncbi.nlm.nih.gov/pubmed/21437151 |
_version_ | 1782199705636175872 |
---|---|
author | Churruca, Juan Vigil, Luis Luna, Esther Ruiz-Galiana, Julian Varela, Manuel |
author_facet | Churruca, Juan Vigil, Luis Luna, Esther Ruiz-Galiana, Julian Varela, Manuel |
author_sort | Churruca, Juan |
collection | PubMed |
description | AIMS: In many physiologic systems, the evolution from health to disease correlates with a loss of complexity in the system’s output. We analyze the difference in complexity of the glycemic profile in healthy volunteers (H), patients with the metabolic syndrome (MS), and patients with type 2 diabetes mellitus (DM). METHODS: We measured interstitial fluid glucose every 5 minutes for 3 days in 10 H, 10 MS, and 10 DM. Complexity of the glycemic profile was evaluated by means of detrended fluctuation analysis (DFA). Mean amplitude of glycemic excursions (MAGE) was also calculated. RESULTS: Glucose profile was more complex (lower DFA) in healthy subjects than in patients with MS or DM (mean DFA [SD]: H: 1.25 (0.10), MS: 1.39 (0.07), DM: 1.42 (0.10). ANOVA: F(2,27) = 9.94, p = 0.001). DM had also a less complex profile than MS, but this difference was not statistically significant. There was an inverse relation between complexity (lower DFA) and the number of MS defining criteria (rho = 0.55, p = 0.002) and between complexity and MAGE (r = 0.68, p < 0.0001). CONCLUSIONS: There is a progressive loss of complexity in the glycemic profile from health, through the metabolic syndrome to type 2 diabetes mellitus. This loss of complexity precedes hyperglycemia and correlates with other markers of disease progression. Complexity analysis may be a useful tool to track the evolution from health to type 2 diabetes. Furthermore, it may provide a way to measure glycemic control in real-life situations and has some distinct advantages over other conventional variability metrics. |
format | Text |
id | pubmed-3052716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-30527162011-03-23 The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes Churruca, Juan Vigil, Luis Luna, Esther Ruiz-Galiana, Julian Varela, Manuel Diabetes Metab Syndr Obes Original Research AIMS: In many physiologic systems, the evolution from health to disease correlates with a loss of complexity in the system’s output. We analyze the difference in complexity of the glycemic profile in healthy volunteers (H), patients with the metabolic syndrome (MS), and patients with type 2 diabetes mellitus (DM). METHODS: We measured interstitial fluid glucose every 5 minutes for 3 days in 10 H, 10 MS, and 10 DM. Complexity of the glycemic profile was evaluated by means of detrended fluctuation analysis (DFA). Mean amplitude of glycemic excursions (MAGE) was also calculated. RESULTS: Glucose profile was more complex (lower DFA) in healthy subjects than in patients with MS or DM (mean DFA [SD]: H: 1.25 (0.10), MS: 1.39 (0.07), DM: 1.42 (0.10). ANOVA: F(2,27) = 9.94, p = 0.001). DM had also a less complex profile than MS, but this difference was not statistically significant. There was an inverse relation between complexity (lower DFA) and the number of MS defining criteria (rho = 0.55, p = 0.002) and between complexity and MAGE (r = 0.68, p < 0.0001). CONCLUSIONS: There is a progressive loss of complexity in the glycemic profile from health, through the metabolic syndrome to type 2 diabetes mellitus. This loss of complexity precedes hyperglycemia and correlates with other markers of disease progression. Complexity analysis may be a useful tool to track the evolution from health to type 2 diabetes. Furthermore, it may provide a way to measure glycemic control in real-life situations and has some distinct advantages over other conventional variability metrics. Dove Medical Press 2008-08-11 /pmc/articles/PMC3052716/ /pubmed/21437151 Text en © 2008 Churruca et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Churruca, Juan Vigil, Luis Luna, Esther Ruiz-Galiana, Julian Varela, Manuel The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes |
title | The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes |
title_full | The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes |
title_fullStr | The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes |
title_full_unstemmed | The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes |
title_short | The route to diabetes: Loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes |
title_sort | route to diabetes: loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052716/ https://www.ncbi.nlm.nih.gov/pubmed/21437151 |
work_keys_str_mv | AT churrucajuan theroutetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT vigilluis theroutetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT lunaesther theroutetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT ruizgalianajulian theroutetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT varelamanuel theroutetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT churrucajuan routetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT vigilluis routetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT lunaesther routetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT ruizgalianajulian routetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes AT varelamanuel routetodiabeteslossofcomplexityintheglycemicprofilefromhealththroughthemetabolicsyndrometotype2diabetes |